§ Funding Round
Series B funding round for Artiva Biotherapeutics raising $120M in February 2021
Series B funding round for Artiva Biotherapeutics raising $120M in February 2021
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — | |
| Organization | — | |
VenrockLEAD | Organization | — |
Acuta Capital Partners | — | — |
| Organization | — | |
| Organization | — | |
Franklin Templeton | — | — |
| Organization | — | |
Green Cross LabCell | — | — |
Janus Henderson Investors | — | — |
Logos Capital | — | — |
| Organization | — | |
| Organization | — | |
Surveyor Capital | — | — |
| Organization | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$198M
Top Valuation
-
Artiva Biotherapeutics raised $120M in a Series B round.
The round was announced on 02/01/21.
The round was led by Venrock.
